We are live on ! Find out more
AWM

Apollon Wealth Management Portfolio holdings

AUM $8.23B
1-Year Est. Return 30.88%
This Fund
S&P 500
This Quarter Est. Return
-3.25%
1 Year Est. Return
+30.88%
3 Year Est. Return
+87.48%
5 Year Est. Return
+103.54%
10 Year Est. Return
–
AUM
$1.41B
AUM Growth
+$69M
Cap. Flow
+$161M
Cap. Flow %
11.43%
Top 10 Hldgs %
24.8%
Holding
850
New
91
Increased
337
Reduced
281
Closed
89

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$76.1M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$53.5M
3
AMZN icon
Amazon
AMZN
+$33.7M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$5.6M
5
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$5.49M

Top Sells

Rank Stock Value
1
QSPT icon
FT Vest Nasdaq-100 Buffer ETF September
QSPT
+$48M
2
MRSH
Marsh
MRSH
+$3.45M
3
TME icon
Tencent Music
TME
+$3.21M
4
QCLN icon
First Trust NASDAQ Clean Edge Green Energy Index Fund
QCLN
+$3.1M
5
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$2.89M

Sector Composition

Rank Sector Weight
1 Technology 16.03%
2 Financials 8.33%
3 Consumer Discretionary 7.27%
4 Healthcare 6.91%
5 Industrials 4.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RLX icon
751
RLX Technology
RLX
$2.46B
$18K ﹤0.01%
+10,000
New +$29.7K
MBIO icon
752
Mustang Bio
MBIO
$4.55M
$15K ﹤0.01%
20
– –
DFTX
753
Definium Therapeutics
DFTX
$6.12B
$13K ﹤0.01%
+762
New +$13.2K
PTN
754
Palatin Technologies
PTN
$13.8M
$13K ﹤0.01%
23
– –
MBII
755
DELISTED
Marrone Bio Innovations, Inc.
MBII
$11K ﹤0.01%
10,000
– –
BIOL
756
DELISTED
Biolase, Inc.
BIOL
$7K ﹤0.01%
8
– –
TXMD icon
757
TherapeuticsMD
TXMD
$24M
$6K ﹤0.01%
300
-29
-9% -$456
SOS
758
SOS Limited
SOS
$14.6M
$5K ﹤0.01%
13
– –
HOOD icon
759
CALL
Robinhood
HOOD
$83.9B
$4K ﹤0.01%
+28,000
New +$374K
SEGG
760
CALL
Sports Entertainment Gaming Global Corp
SEGG
$8.25M
$2K ﹤0.01%
+7
New +$40.1K
ACRE
761
Ares Commercial Real Estate
ACRE
$270M
– –
-10,500
Closed -$153K
AFRM icon
762
Affirm
AFRM
$25.2B
– –
-2,709
Closed -$272K
ALB icon
763
Albemarle
ALB
$15.5B
– –
-919
Closed -$215K
ALGN icon
764
Align Technology
ALGN
$12.3B
– –
-473
Closed -$311K
ARKG icon
765
ARK Genomic Revolution ETF
ARKG
$1.73B
– –
-3,976
Closed -$243K
ATKR icon
766
Atkore
ATKR
$3.16B
– –
-3,099
Closed -$345K
AVAH icon
767
Aveanna Healthcare
AVAH
$2.07B
– –
-16,028
Closed -$713K
AXDX
768
DELISTED
Accelerate Diagnostics
AXDX
– –
-3,200
Closed -$167K
BBCA icon
769
JPMorgan BetaBuilders Canada ETF
BBCA
$11.2B
– –
-8,687
Closed -$584K
BOTZ icon
770
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.51B
– –
-5,695
Closed -$205K
BQ
771
Boqii Holding Ltd
BQ
$6.33M
– –
-55
Closed -$10K
CDW icon
772
CDW
CDW
$17B
– –
-1,404
Closed -$287K
CMMB
773
Chemomab Therapeutics
CMMB
$14.1M
– –
-3,000
Closed -$83K
COR icon
774
Cencora
COR
$61.2B
– –
-3,307
Closed -$439K
CRSP icon
775
CRISPR Therapeutics
CRSP
$5.17B
– –
-5,259
Closed -$399K
29 30
31
32 33

Similar funds

LGF
LGT Group Foundation Vaduz, Liechtenstein $8.19B AUM 27.7% 1-Year Est. Return
CCM
Causeway Capital Management Los Angeles, California $8.15B AUM 29.28% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.82% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return
VIM
Vinva Investment Management Sydney, Australia $8.07B AUM 29.46% 1-Year Est. Return

Apollon Wealth Management's Q1 2022 Portfolio in Review

As of Q1 2022, Apollon Wealth Management held 850 positions worth $1.41B, up 5.2% from $1.34B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Apollon Wealth Management deployed $161M of net new capital in Q1 2022, opening 91 new positions and adding to 337 existing holdings. Its largest new stake was Tandem Diabetes Care: 21,271 shares worth $2.47M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 13% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Marsh, an estimated $3.45M trimmed.

  • Apollon Wealth Management's largest Q1 2022 buy was Tandem Diabetes Care: 21,271 shares worth $2.47M.
  • Apollon Wealth Management added most to Apple in Q1 2022, an estimated $76.1M increase.
  • Apollon Wealth Management's biggest Q1 2022 reduction was Marsh, cutting an estimated $3.45M.
  • Apollon Wealth Management fully exited FT Vest Nasdaq-100 Buffer ETF September in Q1 2022, selling an estimated $48M.
  • Apollon Wealth Management's ten largest holdings make up 25% of its $1.41B portfolio in Q1 2022.
  • Apollon Wealth Management opened 91 new positions and closed 89 in Q1 2022.
  • Apollon Wealth Management's portfolio value rose 5.2% quarter-over-quarter to $1.41B.

Based on Apollon Wealth Management's 13F filing for Q1 2022, filed 16 May 2022.